CYSTO CONRAY INJ 43% DIN 00274194
Health Canada record
| Active ingredient(s) | IOTHALAMATE MEGLUMINE 430 MG |
|---|---|
| Dosage form | Liquid |
| Route | Urethral |
| Schedule | ETHICAL |
| Class | Human |
| ATC | V08AA04 IOTALAMIC ACID |
| Original market date | 31-Dec-1973 |
| Current status date | 15-Mar-2001 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mallinckrodt Canada ULC — licence 102017, currently licensed, last inspection rating C (2024-03-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing IOTHALAMATE MEGLUMINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00223107 | CONRAY 30 | LIEBEL-FLARSHEIM CANADA INC | Solution | IOTHALAMATE MEGLUMINE 300 MG | Cancelled Post Market |
| 00477095 | CONRAY 43 | LIEBEL-FLARSHEIM CANADA INC | Solution | IOTHALAMATE MEGLUMINE 430 MG | Cancelled Post Market |
| 00131237 | CONRAY 60 | LIEBEL-FLARSHEIM COMPANY LLC | Solution | IOTHALAMATE MEGLUMINE 600 MG | Cancelled Post Market |
| 00397466 | CYSTO-CONRAY II | LIEBEL-FLARSHEIM COMPANY LLC | Solution | IOTHALAMATE MEGLUMINE 172 MG | Cancelled Post Market |
| 00131628 | VASCORAY | TYCO HEALTHCARE | Solution | IOTHALAMATE MEGLUMINE 520 MG; IOTHALAMATE SODIUM 260 MG | Cancelled Post Market |